What deal pacing model prevents end-of-quarter ramp-and-stall cycles?

Question

Pulse RevOps · The Machine · Accepted Answer

## Deal Pacing: Smooth Closes vs. Cliff Panic **Direct:** Target **40-45% of quarterly close in week 1-2**, **40% in week 3**, **15-20% in final week**. Inverted curves signal ramp-and-stall (unhealthy, forecast kills). ### Operator Detail End-of-quarter panic closing isn't strategy—it's failure signal. Healthy deals close on rhythm. Learn the curve. **The three close pacing curves:** **Healthy pacing (even distribution):** - Week 1-2: 40-45% of closes (deals move continuously) - Week 3: 35-40% of closes (mid-quarter push) - Week 4: 15-20% of closes (final stragglers, not panic) - Implication: Deals close predictably; forecast variance **±8-12%** - CRO story: "Our close curve is smooth; we don't cram quarter" **Ramp-and-stall (dangerous):** - Week 1-2: 15-20% of closes (early stall) - Week 3: 25-30% of closes (some motion) - Week 4: 55-65% of closes (panic spike) - Signal: Reps didn't manage deals; final week becomes rescue attempt - Forecast variance: **±25-40%** (unpredictable) - Outcome: Hit or miss by $200K+ on $1M quarterly **Backloaded curve (revenue exists but timing fragile):** - Week 1-2: 25% of closes - Week 3: 30% of closes - Week 4: 45% of closes (still elevated) - Root cause: Reps won deals too late in cycle; legal/procurement hoarding - Risk: One delayed signature = entire quarter slips ### Measuring Pacing **Weekly report: % of quarterly revenue closed YTD** | Week | Healthy Target | Ramp-Stall (Bad) | Your Company | Action | |------|--------|--------|---------|--------| | Week 1-2 | 40-45% | 15-20% | 38% | On track | | Week 3 | 75-85% | 40-50% | 72% | Slight behind | | Week 4 | 100% | 95%+ at day 2 | 100% (day 3) | Recovered | ### The Prevention Play **Force Management** research: **87%** of ramp-and-stall patterns come from reps bunching deal activity in final 10 days. Solution: 1. **Daily rep pacing targets** (week 1 = 10% of quota close, not zero) 2. **Deal commitment lock** (by day 5 of quarter, AE must commit signature date) 3. **Early legal review** (legal pre-clears large deals by week 2, not week 4) ### CRO Impact Companies achieving healthy pacing add **$100-300K predictability** per quarter (variance reduction alone). Reps work smarter, not harder at quarter-end. ```mermaid graph TD A["Quarterly Close Curve"] --> B["Healthy Pattern
40% Week 1-2
40% Week 3
20% Week 4"] A --> C["Ramp-and-Stall
20% Week 1-2
25% Week 3
55% Week 4"] A --> D["Backloaded
25% Week 1-2
30% Week 3
45% Week 4"] B --> E["Forecast Variance
±8-12%
Predictable"] C --> F["Forecast Variance
±25-40%
Unreliable"] D --> G["Forecast Variance
±15-25%
Risky"] E --> H["Outcome: Board
Credible reporting"] F --> I["Outcome: Constant
Surprises"] G --> J["Outcome: Acceptable
with vigilance"] ``` TAGS: deal-pacing,close-distribution,quarter-rhythm,deal-timing,forecast-stability,ramp-and-stall

Week	Healthy Target	Ramp-Stall (Bad)	Your Company	Action
Week 1-2	40-45%	15-20%	38%	On track
Week 3	75-85%	40-50%	72%	Slight behind
Week 4	100%	95%+ at day 2	100% (day 3)	Recovered

What deal pacing model prevents end-of-quarter ramp-and-stall cycles?

Deal Pacing: Smooth Closes vs. Cliff Panic

Operator Detail

Measuring Pacing

The Prevention Play

CRO Impact

What does the score mean?